Ranbaxy Infratech India Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
as on 22-06-2024
- Paid Up Capital ₹ 4.50 Cr
as on 22-06-2024
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 6.50 Cr
as on 22-06-2024
- Revenue 37625462.00%
(FY 2016)
- Profit 2362211.00%
(FY 2016)
- Ebitda 3694280.00%
(FY 2016)
- Net Worth 1272.44%
(FY 2016)
- Total Assets 2664.65%
(FY 2016)
About Ranbaxy Infratech India
The Company is engaged in the Infrastructure Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 4.50 Cr.
The company currently has active open charges totaling ₹6.50 Cr.
Leena Nehete, Kamal Chaudhari, and Jayesh Nehete serve as directors at the Company.
- CIN/LLPIN
U45201MH2015PLC260999
- Company No.
260999
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Jan 2015
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Jalgaon, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ranbaxy Infratech India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayesh Nehete  | Managing Director | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamal Chaudhari | Director | 16-Jan-2015 | Current |
| Leena Nehete | Whole-Time Director | 16-Jan-2015 | Current |
Financial Performance and Corporate Structure Insights of Ranbaxy Infratech India.
Ranbaxy Infratech India Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 37625462% increase. The company also saw a substantial improvement in profitability, with a 2362211% increase in profit. The company's net worth Soared by an impressive increase of 1272.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ranbaxy Infratech India?
In 2016, Ranbaxy Infratech India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ramstand Global Limited
Active
14 years 9 months Leena Nehete, Kamal Chaudhari and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Syndicate Bank Creation Date: 29 Jan 2016 | ₹6.50 Cr | Open |
How Many Employees Work at Ranbaxy Infratech India?
Unlock and access historical data on people associated with Ranbaxy Infratech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Apr 20, 2018, Ranbaxy Infratech India has raised a total of ₹ 8.9 Cr, with the most recent deal valued at ₹ 5.67 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
